Stay updated on PRM-151 Efficacy in IPF Clinical Trial
Sign up to get notified when there's something new on the PRM-151 Efficacy in IPF Clinical Trial page.

Latest updates to the PRM-151 Efficacy in IPF Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record for the PRM-151 Phase 2 trial in idiopathic pulmonary fibrosis is displayed, including its design, eligibility criteria, outcomes, locations, and publications.SummaryDifference65%

- Check21 days agoChange DetectedThe page remains a 403 Forbidden error page; its footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe site footer revision identifier changes from v3.7.1 to v3.7.2 while the page remains a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error screen.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows a 403 Forbidden error (with a DOCTYPE and 403 message), replacing the study content and navigation that previously described the record.SummaryDifference20%

Stay in the know with updates to PRM-151 Efficacy in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRM-151 Efficacy in IPF Clinical Trial page.